Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Change in Accured Expenses (2019 - 2025)

AVITA Medical filings provide 7 years of Change in Accured Expenses readings, the most recent being $30000.0 for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses rose 100.96% to $30000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$81000.0, a 93.9% increase, with the full-year FY2025 number at -$81000.0, up 93.9% from a year prior.
  • Change in Accured Expenses hit $30000.0 in Q4 2025 for AVITA Medical, down from $292000.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $3.2 million in Q3 2024 to a low of -$3.1 million in Q4 2024.
  • Median Change in Accured Expenses over the past 5 years was $6000.0 (2021), compared with a mean of $7764.7.
  • The widest YoY moves for Change in Accured Expenses: up 1172.24% in 2024, down 456.2% in 2024.
  • AVITA Medical's Change in Accured Expenses stood at $6000.0 in 2021, then crashed by 2616.67% to -$151000.0 in 2022, then surged by 682.12% to $879000.0 in 2023, then crashed by 456.2% to -$3.1 million in 2024, then surged by 100.96% to $30000.0 in 2025.
  • The last three reported values for Change in Accured Expenses were $30000.0 (Q4 2025), $292000.0 (Q3 2025), and -$1.5 million (Q2 2025) per Business Quant data.